Skip to main contentAll experts

DrDespoina Chrysostomou

Research Associate

Department of Metabolism, Digestion and Reproduction - Faculty of Medicine

Orcid identifier0000-0001-8150-7142 (opens in a new tab)⁠
  • Research Associate
    Department of Metabolism, Digestion and Reproduction - Faculty of Medicine
  • 020 7594 3850 (Work)
  • Queen Elizabeth the Queen Mother Wing (QEQM), St Mary's Campus, United Kingdom

RESEARCH

The role of the microbiome in early cancer detection.

Pharmacomicrobiomics: how the gut microbiome affects drug efficacy and toxicity.

Microbiome-based interventions: Intestinal/ faecal microbiota transplant (IMT/ FMT).

GRANTS

  • STANDARD - CALL
    Trans-POD1UM study: Associate changes in the microbiota composition and function with treatment outcomes in anal cancer
    Incyte Biosciences International Sarl15 Dec 2025 - 14 Dec 2027
    Incyte Biosciences International Sarl: Trans-POD1UM study: Associate changes in the microbiota composition and function with treatment outcomes in anal cancer (2025-2027)
  • STANDARD - CALL
    Targeting the gut microbiome to predict therapy outcomes in pancreatic cancer.
    Pancreatic Cancer UK1 Sep 2025 - 10 Feb 2027
    Pancreatic Cancer UK: Targeting the gut microbiome to predict therapy outcomes in pancreatic cancer. (2025-2027)